Works by CHUNG, CHOON H.

Results: 6
    1

    Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study).

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1527, doi. 10.1111/dom.14061
    By:
    • Kim, Gyuri;
    • Lim, Soo;
    • Kwon, Hyuk‐Sang;
    • Park, Ie B.;
    • Ahn, Kyu J.;
    • Park, Cheol‐Young;
    • Kwon, Su K.;
    • Kim, Hye S.;
    • Park, Seok W.;
    • Kim, Sin G.;
    • Moon, Min K.;
    • Kim, Eun S.;
    • Chung, Choon H.;
    • Park, Kang S.;
    • Kim, Mikyung;
    • Chung, Dong J.;
    • Lee, Chang B.;
    • Kim, Tae H.;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    2

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    3
    4
    5
    6